Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmad Awada

Showing results (141-150 of 311) with videos related to

Pageof 32
Sort By:
Life Sciences|October 15, 2023
Prognostic features of the tumor microenvironment in high-grade serous ovarian cancer and dietary immunomodulationNathalie D McKenzie, Sarfraz Ahmad, Ahmad Awada, et al.
Bulletin Du Cancer|July 31, 2018
Small cell carcinoma of the endometrium: A clinicopathological study and management of three casesFatoumata Matokoma Sidibe, Zakaria Traore, Aspasia Georgala, et al.
The International Journal of Biochemistry & Cell Biology|June 5, 2007
Molecular targeted therapies in breast cancer: where are we now?Christian Widakowich, Evandro de Azambuja, Thierry Gil, et al.
Cold Spring Harbor Molecular Case Studies|March 2, 2023
<i>PIK3CA</i> copy-number gain and inhibitors of the PI3K/AKT/mTOR pathway in triple-negative breast cancerOttavia Amato, Laurence Buisseret, Géraldine Gebhart, et al.
Head & Neck|November 15, 2005
Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluationPhillipe Lothaire, Evandro de Azambuja, Didier Dequanter, et al.
Acta Oto-Laryngologica|October 20, 2006
Does clinical and radiological response predict complete tumor control in N2-N3 squamous cell head and neck cancer after non-operative management of the neck?Didier Dequanter, Philippe Lothaire, Ahmad Awada, et al.
Frontiers in Oncology|December 6, 2021
Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy ResearchMorgane M Cogels, Redouane Rouas, Ghanem E Ghanem, et al.
Annals of the Rheumatic Diseases|January 4, 2014
Potential involvement of the IL-33-ST2 axis in the pathogenesis of primary Sjogren's syndromeAhmad Awada, Charles Nicaise, Sabrina Ena, et al.
Anti-Cancer Drugs|September 10, 2016
Phase I dose-escalation study of plitidepsin in combination with bevacizumab in patients with refractory solid tumorsSandrine Aspeslagh, Ahmad Awada, Arturo S Matos-Pita, et al.
Frontiers in Medicine|October 17, 2017
Hepatoid Adenocarcinoma of the Stomach: A Challenging Diagnostic and Therapeutic Disease through a Case Report and Review of the LiteratureNajla Fakhruddin, Hisham F Bahmad, Tarek Aridi, et al.
Pageof 32

Showing results (141-150 of 311) with videos related to

Sort By:
Pageof 32
Life Sciences|October 15, 2023
Prognostic features of the tumor microenvironment in high-grade serous ovarian cancer and dietary immunomodulationNathalie D McKenzie, Sarfraz Ahmad, Ahmad Awada, et al.
Bulletin Du Cancer|July 31, 2018
Small cell carcinoma of the endometrium: A clinicopathological study and management of three casesFatoumata Matokoma Sidibe, Zakaria Traore, Aspasia Georgala, et al.
The International Journal of Biochemistry & Cell Biology|June 5, 2007
Molecular targeted therapies in breast cancer: where are we now?Christian Widakowich, Evandro de Azambuja, Thierry Gil, et al.
Cold Spring Harbor Molecular Case Studies|March 2, 2023
<i>PIK3CA</i> copy-number gain and inhibitors of the PI3K/AKT/mTOR pathway in triple-negative breast cancerOttavia Amato, Laurence Buisseret, Géraldine Gebhart, et al.
Head & Neck|November 15, 2005
Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluationPhillipe Lothaire, Evandro de Azambuja, Didier Dequanter, et al.
Acta Oto-Laryngologica|October 20, 2006
Does clinical and radiological response predict complete tumor control in N2-N3 squamous cell head and neck cancer after non-operative management of the neck?Didier Dequanter, Philippe Lothaire, Ahmad Awada, et al.
Frontiers in Oncology|December 6, 2021
Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy ResearchMorgane M Cogels, Redouane Rouas, Ghanem E Ghanem, et al.
Annals of the Rheumatic Diseases|January 4, 2014
Potential involvement of the IL-33-ST2 axis in the pathogenesis of primary Sjogren's syndromeAhmad Awada, Charles Nicaise, Sabrina Ena, et al.
Anti-Cancer Drugs|September 10, 2016
Phase I dose-escalation study of plitidepsin in combination with bevacizumab in patients with refractory solid tumorsSandrine Aspeslagh, Ahmad Awada, Arturo S Matos-Pita, et al.
Frontiers in Medicine|October 17, 2017
Hepatoid Adenocarcinoma of the Stomach: A Challenging Diagnostic and Therapeutic Disease through a Case Report and Review of the LiteratureNajla Fakhruddin, Hisham F Bahmad, Tarek Aridi, et al.
Pageof 32